A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Patients With Advanced Small Cell Lung Cancer (SCLC).
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Panobinostat (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 07 Aug 2017 Last checked against European Clinical Trials Database.
- 22 Oct 2010 New trial record